1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (Compound)

Synonyms:84477-87-2, 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE, 1-(5-Isoquinolinylsulfonyl)-2-methylpiperazine, H-7, 5-(2-methylpiperazin-1-yl)sulfonylisoquinoline, 5-(2-methylpiperazine-1-sulfonyl)isoquinoline, Protein kinase inhibitor H-7, Piperazine, 1-(5-isoquinolinylsulfonyl)-2-methyl-, H 7, 5-((2-Methylpiperazin-1-yl)sulfonyl)isoquinoline, MLS000069615, CHEMBL323556, CHEBI:43385, Isoquinoline-5-sulfonic 2-methyl-1-piperazide, 487H9Q0F9N, 5-[(2-methylpiperazin-1-yl)sulfonyl]isoquinoline, SMR000058749, H7, Piperazine, 1-(5-isoquinolinylsulfonyl)-2-methyl-, (2S-(1(R*(R*)),2alpha,3abeta,7abeta))-, 1-(5-ISOQUINOLINYLSULFONYL)-2-METHYL-PIPERAZINE, BRN 5482740, UNII-487H9Q0F9N, H-7 inhibitor, BiomolKI_000004, Opera_ID_1708, BiomolKI2_000014, cid_3542, Protein kinase inhibitor H7, Lopac0_000598, Lopac0_000682, BSPBio_001105, KBioGR_000445, KBioSS_000445, MLS001332489, MLS001332490, Piperazine, 1-(5-isoquinolinylsulfonyl)-2-methyl-, (2S-(1(R*(R*)), 2alpha, 3abeta, 7abeta))-, SCHEMBL190590, SGCUT00137, CHEBI:83438, KBio2_000445, KBio2_003013, KBio2_005581, KBio3_000829, KBio3_000830, BRD6846, Bio1_000431, Bio1_000920, Bio1_001409, Bio2_000383, Bio2_000863, DTXSID401004756, GLXC-26402, HMS1362G07, HMS1792G07, HMS1990G07, HMS2231B22, HMS3374N04, HMS3403G07, BRD-6846, EX-A7026, to_000063, BDBM50216682, AKOS009159179, CCG-100608, DB07996, SDCCGSBI-0050580.P003, IDI1_002138, SMP2_000201, NCGC00015487-05, NCGC00015487-06, NCGC00015487-07, NCGC00015487-08, NCGC00015487-09, NCGC00015487-11, NCGC00015487-12, NCGC00015487-16, NCGC00024640-03, NCGC00024640-04, NCGC00024640-05, NCGC00024640-06, DA-38190, MS-24163, HY-131900, 1-5-Isoquinolinesulphonyl-2-methylpiperazine, CS-0142529, FT-0757321, (+/-)-1-(5-isoquinolinesulfonyl)-2-methylpiperazine, BRD-A55756846-001-05-5, BRD-A55756846-300-01-0, Piperazine, 1-(5-isoquinolinylsulfonyl)-2-methyl- (9CI)

Id:3542

Description:nan